Evotec Se Adr Stock Current Ratio
| EVO Stock | USD 4.68 0.16 3.54% |
Evotec SE ADR fundamentals help investors to digest information that contributes to Evotec SE's financial success or failures. It also enables traders to predict the movement of Evotec Stock. The fundamental analysis module provides a way to measure Evotec SE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evotec SE stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 1.94 | 3.53 |
Evotec | Current Ratio |
Evotec SE ADR Company Current Ratio Analysis
Evotec SE's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Evotec SE Current Ratio | 3.21 X |
Most of Evotec SE's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evotec SE ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Evotec Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Evotec SE is extremely important. It helps to project a fair market value of Evotec Stock properly, considering its historical fundamentals such as Current Ratio. Since Evotec SE's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Evotec SE's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Evotec SE's interrelated accounts and indicators.
Click cells to compare fundamentals
Evotec Current Ratio Historical Pattern
Today, most investors in Evotec SE Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Evotec SE's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Evotec SE current ratio as a starting point in their analysis.
Evotec SE Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
Evotec Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Evotec SE ADR has a Current Ratio of 3.21 times. This is 10.31% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 48.61% lower than that of the firm.
Evotec Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evotec SE's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evotec SE could also be used in its relative valuation, which is a method of valuing Evotec SE by comparing valuation metrics of similar companies.Evotec SE is currently under evaluation in current ratio category among related companies.
Evotec SE Current Valuation Drivers
We derive many important indicators used in calculating different scores of Evotec SE from analyzing Evotec SE's financial statements. These drivers represent accounts that assess Evotec SE's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Evotec SE's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.7B | 2.3B | 3.5B | 1.3B | 1.9B | 2.0B | |
| Enterprise Value | 1.9B | 2.4B | 3.3B | 1.4B | 2.0B | 2.1B |
Evotec SE ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Evotec SE's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Evotec SE's managers, analysts, and investors.Environmental | Governance | Social |
Evotec Fundamentals
| Return On Equity | -0.0791 | ||||
| Return On Asset | 3.0E-4 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 946.82 M | ||||
| Shares Outstanding | 354.37 M | ||||
| Shares Owned By Institutions | 1.40 % | ||||
| Number Of Shares Shorted | 143.67 K | ||||
| Price To Earning | 444.00 X | ||||
| Price To Book | 2.12 X | ||||
| Price To Sales | 3.17 X | ||||
| Revenue | 781.43 M | ||||
| Gross Profit | 151.54 M | ||||
| EBITDA | (7.16 M) | ||||
| Net Income | (83.91 M) | ||||
| Cash And Equivalents | 823.67 M | ||||
| Cash Per Share | 2.33 X | ||||
| Total Debt | 626.2 M | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 6.25 X | ||||
| Cash Flow From Operations | 33.95 M | ||||
| Short Ratio | 0.58 X | ||||
| Earnings Per Share | (0.28) X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 11.64 | ||||
| Number Of Employees | 5.05 K | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 1.66 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | (476.29 M) | ||||
| Working Capital | 438.59 M | ||||
| Five Year Return | 4.88 % | ||||
| Net Asset | 2.3 B |
About Evotec SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evotec SE ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evotec SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evotec SE ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Evotec SE Piotroski F Score and Evotec SE Altman Z Score analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 2.194 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0003 | Return On Equity (0.08) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.